Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Steve R. Turner is active.

Publication


Featured researches published by Steve R. Turner.


Bioorganic & Medicinal Chemistry Letters | 1998

Non-peptidic HIV protease inhibitors: C2-symmetry-based design of bis-sulfonamide dihydropyrones

Musiri N. Janakiraman; Keith D. Watenpaugh; Paul K. Tomich; Chong Kt; Steve R. Turner; Ruben Tommasi; Suvit Thaisrivongs; Joseph Walter Strohbach

Potent, non-peptidic, dihydropyrone sulfonamide HIV protease inhibitors have been previously described. Crystallographic analysis of dihydropyrone sulfonamide inhibitor/HIV protease complexes suggested incorporation of a second, C2 symmetry-related sulfonamide group. Selected bis-sulfonamide dihydropyrone analogues display high HIV protease inhibitory activity.


ACS Medicinal Chemistry Letters | 2010

Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS).

Chris P. Carron; John I. Trujillo; Kirk L. Olson; Wei Huang; Bruce C. Hamper; Tom Dice; Bradley E. Neal; Matthew James Pelc; Jacqueline E. Day; Douglas C. Rohrer; James R. Kiefer; Joseph B. Moon; Barbara Ann Schweitzer; Tanisha D. Blake; Steve R. Turner; Rhonda S. Woerndle; Brenda L. Case; Christine P. Bono; Vickie M. Dilworth; Christie L. Funckes-Shippy; Becky Hood; Gina M. Jerome; Christine M. Kornmeier; Melissa R. Radabaugh; Melanie L. Williams; Michael S. Davies; Craig D. Wegner; Dean Welsch; William M. Abraham; Chad J. Warren

Hematopoietic prostaglandin D synthase (HPGDS) is primarly expressed in mast cells, antigen-presenting cells, and Th-2 cells. HPGDS converts PGH2 into PGD2, a mediator thought to play a pivotal role in airway allergy and inflammatory processes. In this letter, we report the discovery of an orally potent and selective inhibitor of HPGDS that reduces the antigen-induced response in allergic sheep.


Journal of Medicinal Chemistry | 1998

Tipranavir (PNU-140690): A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class∇

Steve R. Turner; Joseph Walter Strohbach; Ruben Tommasi; Paul A. Aristoff; Paul D. Johnson; Harvey I. Skulnick; Lester A. Dolak; Eric P. Seest; Paul K. Tomich; Michael John Bohanon; Miao-Miao Horng; Janet C. Lynn; Chong Kt; Roger R. Hinshaw; Keith D. Watenpaugh; Musiri N. Janakiraman; Suvit Thaisrivongs


Journal of Medicinal Chemistry | 1986

Design and synthesis of potent and specific renin inhibitors containing difluorostatine, difluorostatone, and related analogues

Suvit Thaisrivongs; Donald T. Pals; Warren M. Kati; Steve R. Turner; Lisa M. Thomasco; William Watt


Journal of Medicinal Chemistry | 1996

Structure-based design of HIV protease inhibitors: 5,6-dihydro-4- hydroxy-2-pyrones as effective, nonpeptidic inhibitors

Suvit Thaisrivongs; Donna Lee Romero; Ruben A Tommasi; Musiri N. Janakiraman; Joseph Walter Strohbach; Steve R. Turner; Carolyn Biles; Raymond R. Morge; Paul D. Johnson; Paul Adrian Aristoff; Paul K. Tomich; Janet C. Lynn; Miao Miao Horng; Kong Teck Chong; Roger R. Hinshaw; W. Jeffrey Howe; Barry C. Finzel; Keith D. Watenpaugh


Journal of Medicinal Chemistry | 1988

Conformationally constrained renin inhibitory peptides: gamma-lactam-bridged dipeptide isostere as conformational restriction.

Suvit Thaisrivongs; Donald T. Pals; Steve R. Turner; Lisa T. Kroll


Journal of Medicinal Chemistry | 1987

Renin inhibitors. Design of angiotensinogen transition-state analogues containing novel ((2R,3R,4R,5S)-5-amino-3,4-dihydroxy-2-isopropyl-7-methyloctanoic acid

Suvit Thaisrivongs; Donald T. Pals; Lisa T. Kroll; Steve R. Turner; Fu Son Han


Journal of Medicinal Chemistry | 1987

alpha,alpha-Difluoro-beta-aminodeoxystatine-containing renin inhibitory peptides.

Suvit Thaisrivongs; Heinrich J. Schostarez; Donald T. Pals; Steve R. Turner


Journal of Medicinal Chemistry | 1985

Difluorostatine and difluorostatone containing peptides as potent and specific renin inhibitors

Suvit Thaisrivongs; Donald T. Pals; Warren M. Kati; Steve R. Turner; Lisa M. Thomasco


Journal of Medicinal Chemistry | 1991

Inhibitors of the protease from human immunodeficiency virus : design and modeling of a compound containing a dihydroxyethylene isostere insert with high binding affinity and effective antiviral activity

Suvit Thaisrivongs; Alfredo G. Tomasselli; Joseph B. Moon; John O. Hui; Thomas J. McQuade; Steve R. Turner; Joseph Walter Strohbach; W. Jeffrey Howe; Robert L. Heinrikson

Researchain Logo
Decentralizing Knowledge